# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-24-020831
Filing Date
2024-04-19
Accepted
2024-04-19 17:21:37
Documents
5
Period of Report
2024-06-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | edge20024963x1_pre14a.htm | PRE 14A | 1187546
2 |  | edge20024963x1_pvp01x1.jpg | GRAPHIC | 104703
3 |  | edge20024963x1_pc01.jpg | GRAPHIC | 658479
4 |  | edge20024963x1_pc02.jpg | GRAPHIC | 429831
5 |  | edge20024963x1_pvp02x2.jpg | GRAPHIC | 113840
| Complete submission text file | 0001140361-24-020831.txt |  | 2987683

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33221 | Film No.: 24858959
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)